News
Ray of hope for HIV patients, as Hyderabad-based pharma giants secure nod for game-changing HIV drug
Indian firms have secured rights to produce Lenacapavir, a twice-yearly HIV injection, making treatment easier and affordable ...
31mon MSN
The FDA's approval of lenacapavir, a highly effective HIV prevention drug, sparks debate in India due to its high cost of ₹24 ...
HIV targets the white blood cells and weakens the immune system. This would make the person prone to diseases like ...
Like other PrEP drugs, if enough of the medication is present when a person is exposed to HIV, it can prevent the virus from ...
WASHINGTON — The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step in an anticipated global ...
The National Institutes of Health office responsible for issuing federal guidelines related to treatment of HIV and AIDS ...
New data from a Phase 3 trial show that the daily anti-obesity pill may be as safe and effective as drugs like Mounjaro and ...
The US FDA has approved lenacapavir, the first twice-yearly injection for HIV prevention, which provides near-complete ...
The White House budget proposal would roll back next year's federal HIV prevention funding to levels not seen since around ...
Indian firms have secured rights to produce Lenacapavir, a twice-yearly HIV injection, making treatment easier and affordable. This new drug promises better adherence and wider access, especially in ...
23h
24/7 Wall St. on MSN4 BofA Securities Strong Buy Growth 10 Stocks Also Pay Reliable DividendsInvestors love growth stocks that also pay big and reliable dividends because they provide dependable passive income streams and an excellent opportunity for solid total return. Total return includes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results